Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
ACA, affiliation, alnuctamab, Amelyn, amplify, Arzneimittel, aspire, Avencell, AZ, barred, BeiGene, belonging, bhatt, Biden, Biohaven, blockbuster, blocking, bold, boldly, brain, BridgeBio, capsule, ceiling, cendakimab, Chamber, checkpoint, chemoimmunotherapy, Claudin, clawback, CLL, Codification, cohesive, colorectal, commerce, compassionate, conflict, cornerstone, cut, dataset, decree, deepak, Denmark, deserve, dialogue, discharge, dispense, disproportionately, Dutch, ecteribulin, elevate, Eli, emotional, energized, energizing, EoE, eosinophilic, epidemic, equitable, ESG, ethical, Eureka, Exscientia, factual, farletuzumab, faster, Finland, Genentech, grown, gym, Handa, hardship, HK, hoc, IIB, IIC, Imfinzi, Imjudo, imminent, implicate, inactive, IRA, judge, LaNova, LianBio, longstanding, LOTTE, LP, LSA, Macau, MDRP, membership, Memorial, mental, mindset, motivated, mounted, MPH, MSI, MSS, multicenter, Nanocopoeia, neighboring, neurodegenerative, NKC, Nonrefundable, Norway, NTD, NTRK, obsolete, oncogenic, opdualag, operationalized, overwhelming, PAISLEY, permission, PFS, phototherapy, Pillar, PKC, planet, platinum, polarized, prepaid, pressing, PSO, pursuit, RADIANCE, ratio, reasserted, reevaluated, render, repotrectinib, repricing, resiliency, restrain, role, RS, Russian, saving, sense, serologic, Servier, SHARON, Sherman, sideroblast, skill, SLE, Sotyktu, startup, statutorily, Swedish, Syracuse, tackle, Takeda, TCER, Thailand, Thirteenth, threat, thyroid, tour, transfusion, turn, Turning, unanimously, underway, unlock, upcoming, VAT, vendor, wage, Xspray
Removed:
academic, Acceleron, accept, adjudication, advisory, aided, Anagni, annuity, apremilast, Asia, asserted, ASU, Athene, Azar, Bancroft, behavior, bench, bill, biology, biopharma, blend, burden, cabozantinib, call, capitalization, capped, Catalent, CELMoD, closely, collar, collected, colon, Columbia, converted, Cormorant, CPPIB, credited, declined, deficient, deploying, differentiated, discontinuation, discrete, divest, DLBCL, donut, Dr, DRL, element, encounter, Erbitux, ERISA, Eugia, exchanged, finalized, focusing, forfeiture, forma, FTC, gemoab, genetic, halted, hampered, heightened, hepatocellular, hole, HR, HRSA, idiopathic, ImClone, immunologic, indolent, infusing, ingested, interrupted, intolerant, invalidate, IPF, irrevocably, Jr, KGaA, leaner, lengthen, leveraged, LRR, lump, Luxembourg, Lynch, medically, mismatch, modulator, Mylan, NACHT, Notwithstanding, optimistic, originally, overcome, penalty, Pennsylvania, perception, pill, placement, premium, principle, pro, promise, Prostaglandin, protocol, purport, PYD, randomized, rationalization, Reddy, reengineer, reengineered, repair, replaced, rest, restoring, retained, RRMM, RSU, salesforce, SANTIAGO, SAS, SCCHN, Schmukler, SCLC, shorten, sorafenib, spent, standstill, strike, strongly, suffered, tendered, tradeable, tranche, transformation, transformed, TRICARE, unaudited, unconstitutional, unexercised, unfavorable, unwinding, upper, UPSA, USA, vivo, waiver, weighted, wholly, window, XIa, Zofingen
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Description of Bristol-myers Squibb Companys Securities
- 10 Msu Agreement Under the 2021 Stock Award and Incentive Plan
- 10 Psu Award Agreement Under the 2021 Stock Award and Incentive Plan
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2021 Stock Award and Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2021 Stock Award and Incentive Plan
- 10 Rsu Agreement with 3-YEAR Vesting Under the 2021 Stock Award and Incentive Plan
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2021 Stock Award and Incentive
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2021 Stock Award and Incentive
- 21 EX-21
- 23 EX-23
- 31 EX-31.A
- 31 EX-31.B
- 32 EX-32.A
- 32 EX-32.B
- Download Excel data file
- View Excel data file
Related press release
Associated BMY transcripts
BMY similar filings
Filing view
External links